Entasis Therapeutics Holdings Inc. Gains 176.62%

Wed 18 Mar 20 at 05:30 PM
Entasis Therapeutics Holdings Inc. Gains 176.62%

Entasis Therapeutics Holdings Inc. (ETTX:NASDAQ) shot up at $5.56, a gain of 176.6%. The stock got featured on our News Catalysts scanner on Sat 14 Mar 20 at 02:18 AM in the 'EARNINGS' category. From Tue 03 Mar 20, the stock recorded 20.00% Up Days and 27.27% Green Days

About Entasis Therapeutics Holdings Inc. (ETTX:NASDAQ)

Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. It has the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes etx2514sul, zoliflodacin, etx0282cpdp, and nbp program.

Share